What If Periodontitis and Cardiovascular Disease Share the Same Origin?

By Ayesha Khan, MD, MBA

For decades, the association between periodontal disease and cardiovascular disease (CVD) has been widely reported yet poorly understood. Traditional narratives have often implied a directional relationship—periodontitis contributing to systemic inflammation, bacteremia, and ultimately cardiovascular pathology. While biologically plausible—and supported by the detection of periodontal pathogens such as Porphyromonas gingivalis in atherosclerotic plaques—this causative narrative has increasingly come under scrutiny.

A recent study published in Nature (2026) challenges the conventional causal model, proposing instead that periodontitis and cardiovascular disease are not linked through direct causation, but rather arise from shared genetic and inflammatory mechanisms. This shift—from causation to common origin—has meaningful implications for how dental professionals interpret periodontal findings and engage in interdisciplinary care.

Reframing the Association

The study led by Ting Jin and team utilized large-scale genomic datasets and advanced statistical modeling, including Mendelian randomization, to investigate the relationship between periodontitis and multiple cardiovascular phenotypes—including myocardial infarction, atherosclerosis, and hypertension. The findings were striking: no consistent evidence of direct causality in either direction.

Rather than a linear cause-and-effect relationship, the data supports a model of shared underlying biology. Both periodontitis and cardiovascular disease appear to arise from common upstream determinants, including:

• Dysregulated host immune responses
• Chronic low-grade systemic inflammation
• Altered lipid metabolism
• Genetic variation within key inflammatory signaling pathways

These observations are consistent with prior genome-wide association studies (GWAS), which have identified overlapping genetic loci implicated in both inflammatory and cardiometabolic conditions.

Inflammation as a Common Denominator

Within this framework, chronic inflammation emerges as the central mechanistic axis. Periodontitis is driven by a dysbiotic biofilm that provokes a sustained host-mediated inflammatory response, resulting in connective tissue degradation and alveolar bone loss. In parallel, atherosclerosis is now recognized as a chronic inflammatory disease of the vascular endothelium, characterized by immune activation, lipid accumulation, and progressive plaque formation.

Key mediators including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and C-reactive protein (CRP) are integral to both disease processes. Genetic polymorphisms influencing these pathways may help explain why certain individuals exhibit heightened susceptibility to both periodontal destruction and cardiovascular pathology, even in the absence of a direct causal link.

In this context, genetic predisposition appears to modulate both the magnitude of the host inflammatory response and the efficiency of lipid handling, thereby shaping risk across these seemingly distinct yet biologically convergent conditions.

Epidemiologic Context

It is important to emphasize that the association between periodontitis and cardiovascular disease remains robust across observational studies.

• Severe periodontitis affects approximately 10–15% of the global adult population, representing a significant inflammatory burden.
• Cardiovascular disease remains the leading cause of mortality worldwide, accounting for nearly 19 million deaths annually.
• Multiple cohort studies have demonstrated that individuals with periodontitis have a 20–40% increased relative risk of cardiovascular events.

What the Nature study clarifies is not the presence of this association, but its underlying mechanism. While the correlation remains clear, the idea of a direct cause-and-effect relationship is now far less certain than once believed.

The Mouth as a Window, Not a Trigger

For practicing clinicians, this reframing carries important diagnostic and conceptual implications.

• Risk Interpretation: Severe periodontal findings should prompt consideration of broader systemic risk, rather than assumptions of downstream causality.
• Patient Communication: Discussions can be refined to emphasize shared risk factors—such as smoking, diabetes, and inflammatory dysregulation—rather than overstating causal pathways.
• Interprofessional Collaboration: Periodontal status may serve as an early indicator warranting medical evaluation, particularly in patients without known cardiovascular diagnoses.
• Treatment Expectations: While periodontal therapy remains essential for oral health—and may reduce systemic inflammatory markers, it should not be positioned as a direct intervention for cardiovascular disease prevention based on current genetic evidence.

In this context, the dental operatory becomes a frontline setting for identifying patients who may benefit from further systemic risk assessment.

A Shift in Clinical Perspective

The periodontal–cardiovascular connection is not diminished by these findings—it is clarified. The significance lies not in a causal chain, but in a shared biological origin. Periodontitis and cardiovascular disease are better understood as co-expressions of an underlying inflammatory-genetic landscape, rather than sequential pathologies.

For dental professionals, this reframing elevates the diagnostic value of the periodontal examination. It becomes not only an assessment of local tissue health, but also an indicator of systemic susceptibility. Recognizing this distinction enables a more precise, evidence-based approach to patient care—one that is aligned with the growing emphasis on integrated, interdisciplinary medicine.

References:

1. Jin, T., Lin, J., Zhang, P., Lu, Y., Chen, S., & Lin, H. (2026). Exploring the shared genetic architecture between periodontitis and cardiovascular disease. BDJ Open, 12(1), 28.
2. Wu, L., Huang, C. M., Wang, Q., Wei, J., Xie, L., & Hu, C. Y. (2025). Burden of severe periodontitis: new insights based on a systematic analysis from the Global Burden of Disease Study 2021. BMC Oral Health, 25(1), 861.
3. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
4. Wang, Z., Bao, J., Yang, Y., Wei, Y., Li, C., Pan, Y., & Chen, L. (2025). The Impact of Periodontitis on Cardiovascular Disease: Mechanisms, Evidence, and Therapeutic Implications. International Journal of Dentistry, 2025(1), 3694736.
5. Pavlic, V., Peric, D., Kalezic, I. S., Madi, M., Bhat, S. G., Brkic, Z., & Staletovic, D. (2021). Identification of periopathogens in atheromatous plaques obtained from carotid and coronary arteries. BioMed Research International, 2021(1), 9986375.
6. https://www.genome.gov/genetics-glossary/Genome-Wide-Association-Studies-GWAS

Author: Ayesha Khan, MD, MBA, is a registered physician, former research fellow, and enthusiastic blogger. With a wide range of articles published in renowned newspapers and scientific journals, she covers topics such as nutrition, wellness, supplements, medical research, and alternative medicine. Currently serving as the Vice President of Social Communications and Strategy at Renaissance, Ayesha brings her expertise and strategic mindset to drive impactful initiatives. Follow her blog for insightful content on healthcare advancements and empower yourself with knowledge.